Centrexion Therapeutics, a Boston-based startup led by ex-Pfizer CEO Jeff Kindler, just raised $67 million to bring its painkiller drug into Phase III trials. If it works, the treatment should appease regulators concerned with addiction problems, as the drug is a non-opioid and non-steroid way to treat pain.
{iframe}https://endpts.com/ex-pfizer-ceos-startup-centrexion-gets-67m-for-phiii-painkiller/{/iframe}